Aug 20, 2014 Cellectar Biosciences Reports Second Quarter 2014 Financial Results and Recent Highlights Learn More
Aug 20, 2014 Cellectar Biosciences Announces Closing of Public Offering and Partial Exercise of Underwriter's Over-Allotment Option Learn More
Aug 18, 2014 Cellectar Biosciences to Host Conference Call on August 20th to Discuss Second Quarter 2014 Results and Provide Quarterly Update on Development Progress Learn More
Aug 14, 2014 Cellectar Biosciences Announces Pricing of $12,500,000 Public Offering and Listing on The Nasdaq Capital Market Learn More